American International Group, Inc. Arcellx, Inc. Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$51.85 - $73.49 $8,399 - $11,905	-162 Reduced 0.85%	18,904 $1.31 Million
Q4 2023 Feb 13, 2024	BUY	$31.75 - $57.99 $3,968 - $7,248	125 Added 0.66%	19,066 $1.06 Million
Q3 2023 Nov 13, 2023	BUY	$31.51 - $37.4 $21,206 - $25,170	673 Added 3.68%	18,941 $679,000
Q2 2023 Aug 04, 2023	BUY	$27.49 - $46.9 $109,850 - $187,412	3,996 Added 28.0%	18,268 $577,000
Q1 2023 May 12, 2023	BUY	$26.92 - $33.94 $7,618 - $9,605	283 Added 2.02%	14,272 $439,000
Q4 2022 Feb 10, 2023	SELL	$17.18 - $33.0 $876 - $1,683	-51 Reduced 0.36%	13,989 $433,000
Q3 2022 Nov 14, 2022	BUY	$16.67 - $22.04 $157,348 - $208,035	9,439 Added 205.15%	14,040 $264,000
Q2 2022 Aug 12, 2022	BUY	$7.21 - $24.43 $612 - $2,076	85 Added 1.88%	4,601 $83,000
Q1 2022 May 13, 2022	BUY	$12.97 - $19.14 $58,572 - $86,436	4,516 New	4,516 $63,000

173

45.6M

53.6K

53.7K

Ticker ACLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,819,200
Market Cap $3.63B
Description
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.